406 related articles for article (PubMed ID: 32779318)
1. The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression.
Tu C; Yang K; Wan L; He J; Qi L; Wang W; Lu Q; Li Z
Cell Prolif; 2020 Sep; 53(9):e12887. PubMed ID: 32779318
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between Hippo signalling and miRNAs in tumour progression.
Li N; Xie C; Lu N
FEBS J; 2017 Apr; 284(7):1045-1055. PubMed ID: 27973704
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.
Peng X; Ji C; Tan L; Lin S; Zhu Y; Long M; Luo D; Li H
J Cell Mol Med; 2020 Jan; 24(1):304-316. PubMed ID: 31657132
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer.
Yang G; Shen T; Yi X; Zhang Z; Tang C; Wang L; Zhou Y; Zhou W
J Cell Mol Med; 2018 Apr; 22(4):2062-2070. PubMed ID: 29392884
[TBL] [Abstract][Full Text] [Related]
5. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
[TBL] [Abstract][Full Text] [Related]
6. Emerging role of Hippo signalling pathway in bladder cancer.
Xia J; Zeng M; Zhu H; Chen X; Weng Z; Li S
J Cell Mol Med; 2018 Jan; 22(1):4-15. PubMed ID: 28782275
[TBL] [Abstract][Full Text] [Related]
7. LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism.
Zheng X; Han H; Liu GP; Ma YX; Pan RL; Sang LJ; Li RH; Yang LJ; Marks JR; Wang W; Lin A
EMBO J; 2017 Nov; 36(22):3325-3335. PubMed ID: 28963395
[TBL] [Abstract][Full Text] [Related]
8. Hippo pathway - brief overview of its relevance in cancer.
Zygulska AL; Krzemieniecki K; Pierzchalski P
J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
[TBL] [Abstract][Full Text] [Related]
9. GPCR-Hippo Signaling in Cancer.
Luo J; Yu FX
Cells; 2019 May; 8(5):. PubMed ID: 31072060
[TBL] [Abstract][Full Text] [Related]
10. Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities.
Calses PC; Crawford JJ; Lill JR; Dey A
Trends Cancer; 2019 May; 5(5):297-307. PubMed ID: 31174842
[TBL] [Abstract][Full Text] [Related]
11. From carcinogenesis to therapeutic avenues: lncRNAs and mTOR crosstalk in lung cancer.
Hussain MS; Altamimi ASA; Afzal M; Almalki WH; Kazmi I; Alzarea SI; Saleem S; Prasher P; Oliver B; Singh SK; MacLoughlin R; Dua K; Gupta G
Pathol Res Pract; 2024 Jan; 253():155015. PubMed ID: 38103364
[TBL] [Abstract][Full Text] [Related]
12. Roles of long-non-coding RNAs in cancer therapy through the PI3K/Akt signalling pathway.
Lee KT; Gopalan V; Lam AK
Histol Histopathol; 2019 Jun; 34(6):593-609. PubMed ID: 30620381
[TBL] [Abstract][Full Text] [Related]
13. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
14. Role of cytoplasmic lncRNAs in regulating cancer signaling pathways.
Fu PF; Zheng X; Fan X; Lin AF
J Zhejiang Univ Sci B; 2019 Jan.; 20(1):1-8. PubMed ID: 30614225
[TBL] [Abstract][Full Text] [Related]
15. The Hippo and Wnt signalling pathways: crosstalk during neoplastic progression in gastrointestinal tissue.
Li N; Lu N; Xie C
FEBS J; 2019 Oct; 286(19):3745-3756. PubMed ID: 31342636
[TBL] [Abstract][Full Text] [Related]
16. Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer.
Kim SH; Jin H; Meng RY; Kim DY; Liu YC; Chai OH; Park BH; Kim SM
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547587
[TBL] [Abstract][Full Text] [Related]
17. ZFAS1: A novel vital oncogenic lncRNA in multiple human cancers.
He A; He S; Li X; Zhou L
Cell Prolif; 2019 Jan; 52(1):e12513. PubMed ID: 30288832
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk of lncRNA and Cellular Metabolism and Their Regulatory Mechanism in Cancer.
Lin YH
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331347
[TBL] [Abstract][Full Text] [Related]
19. Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis.
Zhu H; Yu J; Zhu H; Guo Y; Feng S
World J Surg Oncol; 2017 Aug; 15(1):153. PubMed ID: 28797257
[TBL] [Abstract][Full Text] [Related]
20. FAL1: A critical oncogenic long non-coding RNA in human cancers.
Lv X; Li Y; Li Y; Li H; Zhou L; Wang B; Zhi Z; Tang W
Life Sci; 2019 Nov; 236():116918. PubMed ID: 31610208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
